CAR T-Cell Therapies Market
CAR T-Cell Therapies Market
The global CAR T-Cell therapies market is estimated to grow from USD 6.52 billion in 2024 at 29.8% CAGR (2024-2034) to reach an estimated USD 88.51 billion by 2034, as a result of extensive clinical trials, the rising prevalence of cancer, and favorable government policies.
Report ID: 10032
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 6.52 Bn
Forecast Year,
USD USD 88.51 Bn
CAGR, 2025 -
29.8%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
CAR T-Cell Therapies Market Size Analysis
CAR T-Cell Therapies Market Size By Drug Type 2024 to 2034 (USD )
| Drug Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Axicabtagene Ciloleucel | 2282.00 | 2966.27 | 3855.71 | 5011.84 | 6514.62 | 8467.99 | 11007.04 | 14307.37 | 18597.24 | 24173.31 | 31421.21 |
| Tisagenlecleucel | 1956.00 | 2537.20 | 3291.08 | 4268.97 | 5537.43 | 7182.77 | 9317.01 | 12085.38 | 15676.31 | 20334.22 | 26376.11 |
| Brexucabtagene Autoleucel | 1304.00 | 1693.44 | 2199.18 | 2855.96 | 3708.89 | 4816.54 | 6254.99 | 8123.03 | 10548.94 | 13699.34 | 17790.60 |
| Others | 978.00 | 1266.06 | 1638.95 | 2121.65 | 2746.50 | 3555.35 | 4602.38 | 5957.69 | 7712.07 | 9983.00 | 12922.52 |
CAR T-Cell Therapies Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | 2608.00 | 3387.72 | 4400.56 | 5716.20 | 7425.19 | 9645.10 | 12528.69 | 16274.38 | 21139.91 | 27460.06 | 35669.71 |
| Acute Lymphocytic Leukemia | 1304.00 | 1691.75 | 2194.79 | 2847.41 | 3694.09 | 4792.52 | 6217.57 | 8066.36 | 10464.89 | 13576.60 | 17613.58 |
| Chronic Lymphocytic Leukemia (CLL) | 652.00 | 847.14 | 1100.69 | 1430.12 | 1858.15 | 2414.28 | 3136.85 | 4075.68 | 5295.48 | 6880.36 | 8939.55 |
| Multiple Myeloma (MM) | 1304.00 | 1690.90 | 2192.59 | 2843.13 | 3686.68 | 4780.51 | 6198.86 | 8038.03 | 10422.86 | 13515.23 | 17525.07 |
| Others | 652.00 | 845.45 | 1096.30 | 1421.57 | 1843.34 | 2390.25 | 3099.43 | 4019.02 | 5211.43 | 6757.62 | 8762.53 |
CAR T-Cell Therapies Market Size By End User 2024 to 2034 (USD )
| End User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 4564.00 | 5921.53 | 7682.85 | 9968.07 | 12933.00 | 16779.83 | 21770.86 | 28246.43 | 36648.11 | 47548.79 | 61691.78 |
| Cancer Treatment Centers | 1956.00 | 2541.43 | 3302.07 | 4290.36 | 5574.44 | 7242.83 | 9410.55 | 12227.04 | 15886.45 | 20641.07 | 26818.66 |
CAR T-Cell Therapies Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2934.00 | 3806.26 | 4937.83 | 6405.82 | 8310.22 | 10780.78 | 13985.81 | 18143.68 | 23537.63 | 30535.16 | 39612.97 |
| Europe | 1630.00 | 2114.68 | 2743.48 | 3559.26 | 4617.61 | 5990.65 | 7771.97 | 10082.97 | 13081.13 | 16970.79 | 22017.03 |
| Asia-Pacific | 1304.00 | 1694.96 | 2203.14 | 2863.66 | 3722.21 | 4838.15 | 6288.65 | 8173.99 | 10624.54 | 13809.73 | 17949.78 |
| Latin America | 391.20 | 508.15 | 660.06 | 857.39 | 1113.70 | 1446.64 | 1879.11 | 2440.87 | 3170.56 | 4118.38 | 5349.55 |
| Middle East & Africa | 260.80 | 338.91 | 440.41 | 572.30 | 743.70 | 966.43 | 1255.86 | 1631.97 | 2120.71 | 2755.81 | 3581.11 |
CAR T-Cell Therapy Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
